The biochips market is expected to be driven by factors such as personalized medicine growth, technical developments, and use of biochips for cancer treatment across the globe. Owing to these factors, the global market for biochips is expected to double in the next six years However, lack of proper knowledge and healthcare coverage across the globe may pose challenges to the market growth in near future.

London, UK -- (SBWire) -- 02/25/2015 --A biochip is a collection of miniaturized micro array chips that are arranged on a solid substrate. Basically, a microchip is capable of performing huge and ample calculations in one second. For instance, a biochip can perform genes decoding function in a few seconds. Biochips may or may not be electronic and are used as an individual sensor to perform analysis for a specific area. Biochips are majorly used for analyzing gel-based DNA array, plate-based DNA array, and micro fluid biochips. This is expected to drive demand for biochips in near future.

Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-212

The biochips market is expected to be driven by factors such as personalized medicine growth, technical developments, and use of biochips for cancer treatment across the globe. Owing to these factors, the global market for biochips is expected to double in the next six years However, lack of proper knowledge and healthcare coverage across the globe may pose challenges to the market growth in near future.

Apart from geographical categorization, the biochips market can be classified on the type of applications and microarray type. Based on the applications, broadly the categories include diagnostic applications and drug discovery and development. Furthermore, biochip diagnostic applications include neurological diagnostic, cardiac diagnostic, immune disease diagnostic, and others. Biochips classification according to the microarray type includes: protein microarray, lab-on-a chip microarray, and DNA microarray, and others.

Relocation of manufacturing facilities and outsourcing biochip technology are key strategies being followed by participants in this market. In addition, strategic alliances to expand geographical presence and market share along with an enhanced customer base are being followed by companies to grab a significant share in the market. The prominent players of biochips market areBiochain Institute Inc., Cepheid Inc., EMD Millipore, Calipher Life Sciences Inc., Affymetrix Inc., Agilent Technologies Inc., and Sigma Aldrich Corp, among others.

Browse Full Report@ http://www.futuremarketinsights.com/reports/details/biochips-market

This research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product type and distribution channels.

About Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We have a global presence with delivery centres across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery centre located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client.

Browse Press Releases@ http://www.futuremarketinsights.com/pressreleases

Browse Articles@ http://www.futuremarketinsights.com/articles

Browse All Reports@ http://www.futuremarketinsights.com/reports